Novartis (NVS.US) first radioligand therapy drug Piqray dual indications approved simultaneously

Should I invest $2,000 to buy NVS now?
Most investors struggle to provide a definitive answer to this question. While no one can provide absolute guarantees, the most successful traders consistently follow proven best practices, not swayed by market hype or paralyzed by excessive vigilanc


